{"altmetric_id":16819827,"counts":{"readers":{"mendeley":111,"citeulike":0,"connotea":0},"total":{"posts_count":2},"reddit":{"unique_users_count":1,"unique_users":["spyderspyders"],"posts_count":2}},"citation":{"altmetric_jid":"4f6fa4ee3cf058f610002c7a","authors":["Froestl W","Pfeifer A","Muhs A"],"doi":"10.3233\/jad-141206","first_seen_on":"2017-02-27T17:34:31+00:00","issns":["1387-2877"],"journal":"Journal of Alzheimer's Disease","last_mentioned_on":1487981199,"links":["https:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/25061058\/g","https:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/25061058\/"],"pmid":"25061058","pubdate":"2014-07-23T23:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Cognitive Science","scheme":"era"},{"name":"Neurosciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Social Sciences","Psychology"],"subjects":["geriatrics","neurology"],"title":"Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/cognitive-enhancers-nootropics-part-3-drugs-interacting-targets-other-receptors-enzymes-diseasemodif-1"},"altmetric_score":{"score":0.25,"score_history":{"1y":0.25,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":8272014,"mean":6.980828736602,"rank":7153791,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":8272014,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":242022,"mean":13.666697493192,"rank":201532,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":242022,"percentile":1},"this_journal":{"total_number_of_other_articles":2468,"mean":15.348737738143,"rank":2313,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":2468,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":49,"mean":10.164583333333,"rank":48,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":49,"percentile":1}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":3,"Professor > Associate Professor":1,"Librarian":2,"Researcher":21,"Student  > Doctoral Student":6,"Student  > Ph. D. Student":21,"Student  > Postgraduate":8,"Student  > Master":17,"Other":5,"Student  > Bachelor":22,"Lecturer":1,"Professor":4},"by_discipline":{"Materials Science":1,"Medicine and Dentistry":27,"Physics and Astronomy":1,"Psychology":13,"Mathematics":1,"Unspecified":10,"Pharmacology, Toxicology and Pharmaceutical Science":3,"Engineering":7,"Chemistry":13,"Neuroscience":5,"Agricultural and Biological Sciences":20,"Computer Science":4,"Business, Management and Accounting":1,"Nursing and Health Professions":3,"Biochemistry, Genetics and Molecular Biology":2}}},"geo":{"mendeley":{"NL":1,"HU":1,"US":3,"BR":2,"AU":1,"KZ":1,"PT":1,"ES":3,"RU":1}}},"posts":{"reddit":[{"title":"Cognitive enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014.","url":"http:\/\/www.reddit.com\/r\/NootropicResearch\/comments\/5w1468\/cognitive_enhancers_nootropics_part_3_drugs\/","license":"public","citation_ids":[16819827],"posted_on":"2017-02-25T00:06:39+00:00","author":{"id_on_source":"spyderspyders"}},{"title":"Cognitive enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014.","url":"http:\/\/www.reddit.com\/r\/NootropicResearch\/comments\/5w13po\/cognitive_enhancers_nootropics_part_3_drugs\/","license":"public","citation_ids":[16819827],"posted_on":"2017-02-25T00:03:57+00:00","author":{"id_on_source":"spyderspyders"}}]}}